LD-2 disclosure · 3rd Quarter - Report
ABBVIE INC.
via ABBVIE, INC.
Client
- Name
- ABBVIE INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ABBVIE, INC.
- Description
- Biopharmaceutical company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesTrade (domestic/foreign)
Issues related to pharmaceutical tariffs and unfair trade practices
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY
TargetedSENATE · HOUSE OF REPRESENTATIVES · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC)
Copyright/Patent/Trademark
S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
S. 864, HELP Copays Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY
TargetedSENATE · HOUSE OF REPRESENTATIVES